Results 1 to 10 of about 22,013 (249)
Exercise for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 1969 Exercise programmes are a relatively inexpensive, low-risk option compared with other more invasive therapies for leg pain on walking (intermittent claudication (IC)). This is an update of a review first published in 1998.The prime objective of this review was to determine whether an exercise programme in people with intermittent claudication was ...
GC Leng, B Fowler, E. Ernst
+11 more sources
Cilostazol for intermittent claudication. [PDF]
Cochrane Database Syst Rev, 2021 Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown T +5 more
europepmc +10 more sources
Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication [PDF]
Biomedicines, 2023 Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects
Katalin Biró +8 more
doaj +2 more sources
Illness perception, health literacy, self-efficacy, adherence and quality of life in patients with intermittent claudication – a longitudinal cohort study [PDF]
BMC Nursing, 2023 Background Patients with intermittent claudication need lifelong treatment with secondary prevention to prevent cardiovascular events and progression of atherosclerotic disease.
Rebecka Striberger +3 more
doaj +2 more sources
Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers [PDF]
Clinical and Applied Thrombosis/Hemostasis, 2023 Patients with intermittent claudication have significantly higher levels of inflammatory biomarkers, particularly interleukins, which is also a consequence of exercise limitation.
Pavel Poredoš MD, PhD +4 more
doaj +2 more sources
Pentoxifylline for intermittent claudication [PDF]
Медицинский совет, 2015 Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication.
N. A. Vaulin
doaj +5 more sources
Buflomedil for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 2000 Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined.To evaluate the available evidence on the efficacy ...
TLM de Backer +2 more
+10 more sources
Neurogenic Intermittent Claudication [PDF]
Proceedings of the Royal Society of Medicine, 1964 W. A. Bourne
+10 more sources
Intermittent claudication [PDF]
BMJ, 2007 A 58 year old smoker presented with a six month history of pain in the left calf during walking.
Roger W, Simon +3 more
openaire +4 more sources